References
Albright F., Reifenstein E.C. Jr. The parathyroid glands and metabolic bone disease: selected studies. Williams & Wilkins Co., Baltimore, 1948, p. 188.
Riggs B.L., Randall R.V., Wahner H.W., Jowsey J., Kelly P.J., Singh M. The nature of the metabolic bone disorder in acromegaly. J. Clin. Endocrinol. Metab. 1972, 34: 911–918.
Aloia J.F., Zanzi I., Ellis K., Jowsey J., Roginsky M., Wallach S., Cohn S.H. Effects of growth hormone in osteoporosis. J. Clin. Endocrinol. Metab. 1976, 43: 992–999.
Seeman E., Wahner H.W., Offord P., Kumar R., Johnson W.J., Riggs B.L. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J. Clin. Invest. 1982, 69: 1302–1309.
Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human ageing. Endocr. Rev. 1993, 14: 20–39.
Rudman D. Growth hormone, body composition and ageing. J. Am. Geriatr. Soc. 1985, 33: 800–807.
Kelijman M. Age-related alterations of the growth hormone/insulin- like-growth-factor axis. J. Am. Geriatr. Soc. 1991, 39: 295–307.
Romagnoli E., Minisola S., Carnevale V., Scarda A., Rosso R., Scarnecchia L., Pacitti M.T., Mazzuoli G. Effect of oestrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif. Tissue Int. 1993, 53: 1–6.
Inzucchi S.E., Robbins R.J. Effects of growth hormone on human bone biology. J. Clin. Endocrinol. Metab. 1994, 79: 691–694.
Canalis E. Systemic and local factors and the maintenance of bone quality. Calcif. Tissue Int. 1993, 53 (Suppl. 1): S90–S93.
Rudman D., Feller A.G., Nagraj H.S., Gergans G.A., Lalitha P.Y., Goldberg A.F., Schlenker R.A., Cohn L., Rudman I.W., Mattson D.E. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 1990, 323: 1–6.
van der Veen E.A., Netelembos J.C. Growth hormone (replacement) therapy in adults: bone and calcium metabolism. Horm. Metab. Res. 1990, 33 (Suppl. 4): 65–68.
Wüster C. Growth hormone and bone metabolism. Acta Endocrinol. 1993, 128 (Suppl. 2): 14–18.
Slootweg M.J. Growth hormone and bone. Horm. Metab. Res. 1993, 25: 335–347.
Halse J., Gordeladze J.O. Total and non-dyalizable urinary hydroxyproline in acromegalics and control subjects. Acta Endocrinol. 1981, 96: 451–457.
De la Piedra C., Larranaga E.C.J., Castro N., Horcajada C., Rapado A., Herrera Pombo J.L. Correlation among plasma osteocalcin, growth hormone, and somatomedin-C in acromegaly. Calcif. Tissue Int. 1988, 43: 44–45.
Halse J., Melsen F., Mosekilde L. Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinol. (Copenh.) 1981, 97: 18–22.
Ezzat S., Melmed S., Endres D., Eyre D.R., Singer F.R. Biochemical assessment of bone formation and resorption in acromegaly. J. Clin. Endocrinol. Metab. 1993, 76: 1452–1457.
Kotzmann H., Bernecker P., Hübsch P., Pietschmann P., Woloszcuk W., Svoboda T., Geyer G., Luger A. Bone mineral density and parameters of bone metabolism in patients with acromegaly. J. Bone Miner. Res. 1993, 8: 459–465.
Diamond T., Nery L., Posen S. Spinal and peripheral bone mineral densities in acromegaly. The effects of excess growth hormone and hypogonadism. Ann. Intern. Med. 1989, 11: 567–573.
Ho P.J., Fig L. M., Barkan A.L., Shapiro B. Bone mineral density of the axial skeleton in acromegaly. J. Nucl. Med. 1992, 33: 1608–1612.
Jockenhovel F., Rohrbach S., Deggerich S., Reinwein D., Reiners C. Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly. Eur. J. Med. Res. 1996, 1: 377–382.
Kayath M.J., Vieira J.G. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporos. Int. 1997, 7: 226–230.
Lesse G.P., Fraser D., Farquharson R., Hipkin L., Vora L.P. Gonadal status is an important determinant of bone density in acromegaly. Clin. Endocrinol. (Oxf.) 1998, 48: 59–65.
Scillitani A., Chiodini I., Carnevale V., Giannatempo G.M., Frusciante V., Villella M., Pileri M., Guglielmi G., Di Giorgio A., Modoni S., Fusilli S., Di Cerbo A., Liuzzi A. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients. J. Bone Miner. Res. 1997, 12: 1729–1736.
Longobardi S., Di Somma C., Di Rella C., Angelillo N., Ferone D., Colao A., Merola B. Bone mineral density and circulating cytokines in patients with acromegaly. J. Endocrinol. Invest. 1998, 21: 688–693.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiodini, I., Trischitta, V., Carnevale, V. et al. Bone mineral density in acromegaly: Does growth hormone excess protect against osteoporosis?. J Endocrinol Invest 24, 288–291 (2001). https://doi.org/10.1007/BF03343859
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343859